Dewpoint Therapeutics
USEntry
2019
Hold
7yr
Status
Active
Who owns Dewpoint Therapeutics?
Dewpoint Therapeutics is currently owned by Leaps by Bayer through Leaps by Bayer (2015 vintage), since 2019. Across its history, Dewpoint Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Leaps by BayerLeaps by Bayer · 2015 · Evergreen
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2019 · present
Leaps by BayerActive
2019 · present(7yr) · Leaps by Bayer · 2015 · Evergreen
Mubadala CapitalActive
2019 · present(7yr) · Mubadala Capital Other Investments · Buyout
More from Leaps by Bayer
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Dewpoint Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Dewpoint Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue